Is Teduglutide (Gattex / Revestive) legal?
Teduglutide (Gattex / Revestive) is an FDA approved drug. For drug-tested athletes it is not on the WADA prohibited list. Yes, gastroenterology specialists prescribe for short-bowel-syndrome patients.. Legal status depends on your country and changes over time. This reflects US status at the time of writing and is not legal or medical advice.
Regulatory status
- FDA: Approved as Gattex / Revestive (2012) for short bowel syndrome with intestinal failure.
- WADA: Not listed
- Prescription: Yes, gastroenterology specialists prescribe for short-bowel-syndrome patients.
References
- Teduglutide for the Treatment of Short Bowel Syndrome — Schwartz LK et al., NEJM, 2012
- Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure — Jeppesen PB, Pertkiewicz M, Messing B, et al. — Gastroenterology, 2012 (STEPS trial)
- GATTEX (teduglutide) for injection — FDA Prescribing Information — FDA / DailyMed (Takeda)
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Teduglutide (Gattex / Revestive)
Last updated 2026-06-06.